<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84893718474</prism:url><dc:identifier>SCOPUS_ID:84893718474</dc:identifier><eid>2-s2.0-84893718474</eid><pubmed-id>24382831</pubmed-id><prism:doi>10.1002/btpr.1848</prism:doi><dc:title>Development of at-line assay to monitor charge variants of MAbs during production</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>2</citedby-count><prism:publicationName>Biotechnology Progress</prism:publicationName><source-id>15541</source-id><prism:issn>87567938</prism:issn><prism:volume>30</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:startingPage>249</prism:startingPage><prism:endingPage>255</prism:endingPage><prism:pageRange>249-255</prism:pageRange><prism:coverDate>2014-01-01</prism:coverDate><dc:creator><author auid="8275356100" seq="1"><ce:initials>M.M.S.</ce:initials><ce:indexed-name>Amand M.M.S.</ce:indexed-name><ce:surname>Amand</ce:surname><ce:given-name>M.M. St.</ce:given-name><preferred-name>
<ce:initials>M.M.S.</ce:initials>
<ce:indexed-name>Amand M.</ce:indexed-name>
<ce:surname>Amand</ce:surname>
<ce:given-name>M. M St</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/8275356100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60023004" id="60023004"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng">
<ce:para>One major challenge currently facing the biopharmaceutical industry is to understand how MAb microheterogeneity affects therapeutic efficacy, potency, immunogenicity, and clearance. MAb micro-heterogeneity can result from post-translational modifications such as sialylation, galactosylation, C-terminal lysine cleavage, glycine amidation, and tryptophan oxidation, each of which can generate MAb charge variants; such heterogeneity can affect pharmacokinetics (PK) considerably. Implementation of appropriate on-line quality control strategies may help to regulate bioprocesses, thus enabling more homogenous material with desired post-translational modifications and PK behavior. However, one major restriction to implementation of quality control strategies is the availability of techniques for obtaining on-line or at-line measurements of these attributes. In this work, we describe the development of an at-line assay to separate MAb charge variants in near real-time, which could ultimately be used to implement on-line quality control strategies for MAb production. The assay consists of a 2D-HPLC method with sequential in-line Protein A and WCX-10 HPLC column steps. To perform the 2D-HPLC assay at-line, the two columns steps were integrated into a single method using a novel system configuration that allowed parallel flow over column 1 or column 2 or sequential flow from column 1 to column 2. A bioreactor system was also developed such that media samples could be removed automatically from bioreactor vessels during production and delivered to the 2D-HPLC for analysis. With this at-line HPLC assay, we have demonstrated that MAb microheterogeneity occurs throughout the cell cycle whether the host cell line is grown under different or the same nominal culture conditions. Â© 2013 American Institute of Chemical Engineers.</ce:para>
</abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84893718474" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84893718474&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-84893718474%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60023004" id="60023004"><affilname>University of Delaware</affilname></affiliation><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60017672" id="60017672"><affilname>Tulane University</affilname></affiliation><authors><author auid="8275356100" seq="1"><ce:initials>M.M.S.</ce:initials><ce:indexed-name>Amand M.M.S.</ce:indexed-name><ce:surname>Amand</ce:surname><ce:given-name>M.M. St.</ce:given-name><preferred-name>
<ce:initials>M.M.S.</ce:initials>
<ce:indexed-name>Amand M.</ce:indexed-name>
<ce:surname>Amand</ce:surname>
<ce:given-name>M. M St</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/8275356100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60023004" id="60023004"/></author><author auid="7003672336" seq="2"><ce:initials>B.A.</ce:initials><ce:indexed-name>Ogunnaike B.A.</ce:indexed-name><ce:surname>Ogunnaike</ce:surname><preferred-name>
<ce:initials>B.A.</ce:initials>
<ce:indexed-name>Ogunnaike B.</ce:indexed-name>
<ce:surname>Ogunnaike</ce:surname>
<ce:given-name>B. A.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7003672336</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60023004" id="60023004"/></author><author auid="7403387058" seq="3"><ce:initials>A.S.</ce:initials><ce:indexed-name>Robinson A.S.</ce:indexed-name><ce:surname>Robinson</ce:surname><preferred-name>
<ce:initials>A.S.</ce:initials>
<ce:indexed-name>Robinson A.</ce:indexed-name>
<ce:surname>Robinson</ce:surname>
<ce:given-name>A. S.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7403387058</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60023004" id="60023004"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60017672" id="60017672"/></author></authors></abstracts-retrieval-response>
